Please assess the completion status of the following clinical trial:

Trial Title: Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~Diagnosis of schizophrenia or schizoaffective disorder, smoke 20-50 cpd, clinically stable on antipsychotic and antidepressant medications~Exclusion Criteria:~Pregnant/nursing women, seizure disorder, lowered seizure threshold due to other medical conditions, positive urine drug screen positive breath alcohol test, past 2 weeks use of MAO inhibitors, any form of bupropion, cimetidine, phenobarbital, phenytoin, DA agonists, anorectics, stimulants

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): Contingent reinforcement plus bupropion
- 2 (Type: EXPERIMENTAL): Contingent reinforcement plus placebo
- 3 (Type: EXPERIMENTAL): Non-contingent reinforcement plus bupropion
- 4 (Type: PLACEBO_COMPARATOR): Non-contingent reinforcement plus placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).